ASSESSING THE ECONOMIC BURDEN OF PROSTATE CANCER IN UGANDA

Author(s)

Seninde IK, Knoll B
Health Outcomes Measures and Analysis Lab (U) Ltd, Kampala, Uganda

OBJECTIVES: Despite advancements and improvements in cancer care typically experienced by developed economies in the recent decades, the cascade of these benefits to developing economies has been slow. As such, conditions such as prostate cancer continue to substantially impact health systems and populations of countries like Uganda. This study assessed the burden of prostate cancer in Uganda.

METHODS: This was retrospective analysis of data abstracted from medical records of prostate cancer patients across three private cancer centers and two cancer referral hospitals in five districts in Uganda (i.e., Kampala, Wakiso, Gulu, Mbarara, and Jinja). Abstracted data focused on economic and clinical burden of disease, and analyses were descriptive.

RESULTS: Medical records were abstracted for a total of 1,791 patients treated in these centers over the period covering January 1st

Conference/Value in Health Info

2018-05, ISPOR 2018, Baltimore, MD, USA

Value in Health, Vol. 21, S1 (May 2018)

Code

PCN76

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×